DGA GROUP GOVERNMENT RELATIONS LLC

Lobbying for VIIV HEALTHCARE · Biopharmaceutical company focused on HIV prevention and treatment

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · North Carolina · House · Senate · $10,000.00 income · posted Jan 15, 2026

Lobbying activity 1

Trade (domestic/foreign)

Defense of US pharmaceutical intellectual property rights and incentives

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.